Global Sleep Apnea Device Market Research Report—Forecast till 2027

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 18 2.2 RESEARCH OBJECTIVE 18 2.3 MARKET STRUCTURE 18 2.4 ASSUMPTIONS & LIMITATIONS 19 3 RESEARCH METHODOLOGY 3.1 DATA MINING 20 3.2 SECONDARY RESEARCH 21 3.3 PRIMARY RESEARCH 21 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22 3.5 FORECASTING TECHNIQUES 23 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24 3.6.1 BOTTOM-UP APPROACH 25 3.6.2 TOP-DOWN APPROACH 25 3.7 DATA TRIANGULATION 25 3.8 VALIDATION 26 4 MARKET DYNAMICS 4.1 OVERVIEW 27 4.2 DRIVERS 28 4.2.1 TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES 28 4.2.2 GROWING USAGE OF ORAL APPLIANCES 28 4.2.3 RISING PREVALENCE OF SLEEP APNEA 28 4.2.4 BOOMING GERIATRIC POPULATION 28 4.2.5 INCREASING OBESITY 29 4.3 RESTRAINTS 29 4.3.1 UNDIAGNOSED POPULATION 29 4.3.2 HIGH COST OF DEVICES 30 4.4 OPPORTUNITIES 30 4.4.1 GROWING INVESTMENT IN R&D ACTIVITIES TO LAUNCH NOVEL PRODUCTS 30 4.5 COVID-19 IMPACT ANALYSIS 31 4.5.1 IMPACT ON SUPPLY CHAIN 31 4.5.2 IMPACT ON PRICING 31 4.5.3 IMPACT ON KEY PLAYERS 31 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 32 5.1.1 R&D AND DESIGNING 33 5.1.2 MANUFACTURING 33 5.1.3 DISTRIBUTION & SALES 33 5.1.4 POST-SALES MONITORING 33 5.2 PORTER’S FIVE FORCES MODEL 34 5.2.1 BARGAINING POWER OF SUPPLIERS 35 5.2.2 BARGAINING POWER OF BUYERS 35 5.2.3 THREAT OF NEW ENTRANTS 35 5.2.4 THREAT OF SUBSTITUTES 35 5.2.5 RIVALRY 35 6 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE 6.1 OVERVIEW 36 6.2 DIAGNOSTIC DEVICES 37 6.2.1 POLYSOMNOGRAPHY DEVICES 38 6.2.2 HOME SLEEP TESTING DEVICES 38 6.2.3 PULSE OXIMETERS 39 6.2.4 SLEEP SCREENING DEVICES 39 6.3 THERAPEUTIC DEVICES 40 6.3.1 POSITIVE AIRWAY PRESSURE DEVICES 41 6.3.1.1 AUTOMATIC POSITIVE AIRWAY PRESSURE DEVICES 42 6.3.1.2 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES 42 6.3.1.3 BILEVEL POSITIVE AIRWAY PRESSURE DEVICES 42 6.3.2 FACIAL INTERFACES 43 6.3.2.1 FULL-FACE MASKS 44 6.3.2.2 NASAL PILLOW MASKS 44 6.3.2.3 NASAL MASKS 44 6.3.3 ACCESSORIES 45 6.3.3.1 HUMIDIFIER ACCESSORIES 46 6.3.3.2 POWER ACCESSORIES 46 6.3.3.3 TRANSPORTATION ACCESSORIES 46 6.3.3.4 COMMUNICATION ACCESSORIES 47 6.3.3.5 CHIN RESTRAINTS 47 6.3.4 ORAL APPLIANCES 48 6.3.4.1 MANDIBULAR ADVANCEMENT DEVICES 49 6.3.4.2 TONGUE-RETAINING DEVICES 49 6.3.5 ADAPTIVE SERVO-VENTILATORS 49 6.3.6 SURGICAL DEVICES 50 7 GLOBAL SLEEP APNEA DEVICES MARKET, BY END USER 7.1 OVERVIEW 51 7.2 HOME CARE SETTINGS 51 7.3 SLEEP LABORATORIES & HOSPITALS 52 7.4 OTHERS 52 8 GLOBAL SLEEP APNEA DEVICES MARKET, BY REGION 8.1 OVERVIEW 53 8.2 AMERICAS 55 8.2.1 NORTH AMERICA 58 8.2.1.1 US 62 8.2.1.2 CANADA 64 8.2.2 LATIN AMERICA 67 8.3 EUROPE 70 8.3.1 WESTERN EUROPE 73 8.3.1.1 GERMANY 77 8.3.1.2 FRANCE 79 8.3.1.3 UK 82 8.3.1.4 ITALY 85 8.3.1.5 SPAIN 87 8.3.1.6 REST OF WESTERN EUROPE 90 8.3.2 EASTERN EUROPE 93 8.4 ASIA-PACIFIC 96 8.4.1 CHINA 99 8.4.2 JAPAN 102 8.4.3 INDIA 105 8.4.4 AUSTRALIA 107 8.4.5 SOUTH KOREA 110 8.4.6 REST OF ASIA-PACIFIC 113 8.5 MIDDLE EAST & AFRICA 116 8.5.1 MIDDLE EAST 119 8.5.2 AFRICA 122 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 125 9.2 COMPETITIVE BENCHMARKING 126 9.3 MAJOR GROWTH STRATEGY IN THE SLEEP APNEA DEVICE MARKET 127 9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 128 9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 128 9.5.1 ACQUISITIONS 129 9.6 FINANCIAL MATRIX 130 10 COMPANY PROFILES 10.1 KONINKLIJKE PHILIPS NV (PHILIPS) 131 10.1.1 COMPANY OVERVIEW 131 10.1.2 FINANCIAL OVERVIEW 132 10.1.3 PRODUCTS/SERVICES OFFERED 132 10.1.4 KEY DEVELOPMENTS 133 10.1.5 SWOT ANALYSIS 133 10.1.6 KEY STRATEGIES 134 10.2 RESMED 135 10.2.1 COMPANY OVERVIEW 135 10.2.2 FINANCIAL OVERVIEW 135 10.2.3 PRODUCTS/SERVICES OFFERED 136 10.2.4 KEY DEVELOPMENTS 136 10.2.5 SWOT ANALYSIS 137 10.2.6 KEY STRATEGIES 137 10.3 LIVA NOVA (CYBERONICS) 138 10.3.1 COMPANY OVERVIEW 138 10.3.2 FINANCIAL OVERVIEW 138 10.3.3 PRODUCTS/SERVICES OFFERED 139 10.3.4 KEY DEVELOPMENTS 139 10.3.5 SWOT ANALYSIS 140 10.3.6 KEY STRATEGIES 140 10.4 COMPUMEDICS 141 10.4.1 COMPANY OVERVIEW 141 10.4.2 FINANCIAL OVERVIEW 141 10.4.3 PRODUCTS/SERVICES OFFERED 142 10.4.4 KEY DEVELOPMENTS 142 10.4.5 SWOT ANALYSIS 142 10.4.6 KEY STRATEGIES 143 10.5 NIHON KOHDEN 144 10.5.1 COMPANY OVERVIEW 144 10.5.2 FINANCIAL OVERVIEW 144 10.5.3 PRODUCTS/SERVICES OFFERED 145 10.5.4 KEY DEVELOPMENTS 145 10.5.5 SWOT ANALYSIS 146 10.5.6 KEY STRATEGIES 146 10.6 GE HEALTHCARE 147 10.6.1 COMPANY OVERVIEW 147 10.6.2 FINANCIAL OVERVIEW 147 10.6.3 PRODUCTS/SERVICES OFFERED 148 10.6.4 KEY DEVELOPMENTS 148 10.6.5 SWOT ANALYSIS 148 10.6.6 KEY STRATEGIES 148 10.7 NATUS MEDICAL INCORPORATED 149 10.7.1 COMPANY OVERVIEW 149 10.7.2 FINANCIAL OVERVIEW 149 10.7.3 PRODUCTS/SERVICES OFFERED 150 10.7.4 KEY DEVELOPMENTS 150 10.7.5 SWOT ANALYSIS 151 10.7.6 KEY STRATEGIES 151 10.8 BMC MEDICAL CO.LTD. 152 10.8.1 COMPANY OVERVIEW 152 10.8.2 FINANCIAL OVERVIEW 152 10.8.3 PRODUCTS/SERVICES OFFERED 152 10.8.4 KEY DEVELOPMENTS 152 10.8.5 SWOT ANALYSIS 153 10.8.6 KEY STRATEGIES 153 10.9 CADWELL LABORATORIES 154 10.9.1 COMPANY OVERVIEW 154 10.9.2 FINANCIAL OVERVIEW 154 10.9.3 PRODUCTS/SERVICES OFFERED 154 10.9.4 KEY DEVELOPMENTS 154 10.9.5 SWOT ANALYSIS 155 10.9.6 KEY STRATEGIES 155 10.10 CURATIVE MEDICAL INC. 156 10.10.1 COMPANY OVERVIEW 156 10.10.2 FINANCIAL OVERVIEW 156 10.10.3 PRODUCTS/SERVICES OFFERED 156 10.10.4 KEY DEVELOPMENTS 156 10.10.5 SWOT ANALYSIS 157 10.10.6 KEY STRATEGIES 157 11 APPENDIX 11.1 REFERENCES 158 11.2 RELATED REPORTS 158